Imaging of cellular therapies

Advanced Drug Delivery Reviews

Volumn 62, Issue 11, 2010, Pages 1080-1093

  Srinivas, M ^a   Aarntzen, E H J G ^a,b   Bulte, J W M ^c   Oyen, W J ^b   Heerschap, A ^b   de Vries, I J M ^a   Figdor, C G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapeutics; Cell therapy; Cell tracking; Clinical trial; CT; MRI; PET; SPECT

Indexed keywords

CELL THERAPY; CELL TRACKING; CLINICAL TRIAL; CT; MRI; PET; SPECT;

COMPUTERIZED TOMOGRAPHY; CYTOLOGY; EXPERIMENTS; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; RESONANCE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

CELLS;

8 QUINOLINOL INDIUM IN 111; FLUORESCENT DYE; FLUORINE 18; FLUOROCARBON; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IRON OXIDE; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TECHNETIUM 99M;

ADOPTIVE TRANSFER; ALZHEIMER DISEASE; BIOLUMINESCENCE; BRAIN INJURY; CANCER IMMUNOTHERAPY; CARDIOMYOPATHY; CELL COUNT; CELL LABELING; CELL THERAPY; CELL VIABILITY; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DENDRITIC CELL; FLUORESCENCE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MESENCHYMAL STEM CELL; MOLECULAR IMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE;

ANIMALS; CELL TRACKING; CELL TRANSPLANTATION; DENDRITIC CELLS; DIAGNOSTIC IMAGING; HUMANS; T-LYMPHOCYTES;

EID: 78649334161     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.08.009     Document Type: Review

References (101)

1. van der Windt D.J., Echeverri G.J., Ijzermans J.N., Cooper D.K. The choice of anatomical site for islet transplantation. Cell Transplant. 2008, 17:1005-1014.
2. McAfee J.G., Samin A. In-111 labeled leukocytes: a review of problems in image interpretation. Radiology 1985, 155:221-229.
3. Palestro C.J., Love C., Bhargava K.K. Labeled leukocyte imaging: current status and future directions. Q. J. Nucl. Med. Mol. Imaging 2009, 53:105-123.
4. Bleeker-Rovers C.P., van der Meer J.W., Oyen W.J. Fever of unknown origin. Semin. Nucl. Med. 2009, 39:81-87.
5. Barentsz J.O., Futterer J.J., Takahashi S. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. Eur. J. Radiol. 2007, 63:369-372.
6. Kim J.A., Bresler H.S., Martin E.W., Aldrich W., Heffelfinger M., Triozzi P.L. Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody. Cancer 1999, 86:22-30.
7. Thompson M., Wall D.M., Hicks R.J., Prince H.M. In vivo tracking for cell therapies. Q. J. Nucl. Med. Mol. Imaging 2005, 49:339-348.
8. Gilad A.A., Ziv K., McMahon M.T., van Zijl P.C., Neeman M., Bulte J.W. MRI reporter genes. J. Nucl. Med. 2008, 49:1905-1908.
9. Modo M. Noninvasive imaging of transplanted cells. Curr. Opin. Organ Transplant. 2008, 13:654-658.
10. Preynat-Seauve O., Burkhard P.R., Villard J., Zingg W., Ginovart N., Feki A., Dubois-Dauphin M., Hurst S.A., Mauron A., Jaconi M., Krause K.H. Pluripotent stem cells as new drugs? The example of Parkinson's disease. Int. J. Pharm. 2009, 381:113-121.
11. Kiessling F. Noninvasive cell tracking. Handb. Exp. Pharmacol. 2008, 305-321.
12. Toso C., Vallee J.P., Morel P., Ris F., Demuylder-Mischler S., Lepetit-Coiffe M., Marangon N., Saudek F., James Shapiro A.M., Bosco D., Berney T. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am. J. Transplant. 2008, 8:701-706.
13. de Vries I.J., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., Oyen W.J., Bonenkamp J.J., Boezeman J.B., Adema G.J., Bulte J.W., Scheenen T.W., Punt C.J., Heerschap A., Figdor C.G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005, 23:1407-1413.
14. Bueno E.M., Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat. Rev. Rheumatol. 2009, 5:685-697.
15. De Vries I.J., Krooshoop D.J., Scharenborg N.M., Lesterhuis W.J., Diepstra J.H., Van Muijen G.N., Strijk S.P., Ruers T.J., Boerman O.C., Oyen W.J., Adema G.J., Punt C.J., Figdor C.G. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003, 63:12-17.
16. Verdijk P., Aarntzen E.H., Punt C.J., de Vries I.J., Figdor C.G. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin. Biol. Ther. 2008, 8:865-874.
17. Bulte J.W. In vivo MRI cell tracking: clinical studies. AJR Am. J. Roentgenol. 2009, 193:314-325.
18. Schafer R., Bantleon R., Kehlbach R., Siegel G., Wiskirchen J., Wolburg H., Kluba T., Eibofner F., Northoff H., Claussen C.D., Schlemmer H.P. Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles. BMC Cell Biol 2008, 11:22.
19. Suzuki Y., Zhang S., Kundu P., Yeung A.C., Robbins R.C., Yang P.C. In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn. Reson. Med. 2007, 57:1173-1179.
20. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 2004, 10:475-480.
21. Rosenberg S.A., Restifo N.P., Yang J.C., Morgan R.A., Dudley M.E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 2008, 8:299-308.
22. Walczak P., Kedziorek D.A., Gilad A.A., Barnett B.P., Bulte J.W. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 2007, 58:261-269.
23. Blocklet D., Toungouz M., Kiss R., Lambermont M., Velu T., Duriau D., Goldman M., Goldman S. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:440-447.
24. Kedziorek D.A., Muja N., Walczak P., Ruiz-Cabello J., Gilad A.A., Jie C.C., Bulte J.W. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn. Reson. Med. 2010, 63:1031-1043.
25. Long C.M., van Laarhoven H.W., Bulte J.W., Levitsky H.I. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res. 2009, 69:3180-3187.
26. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. rev. 2005, 5:296-306.
27. Lesterhuis W.J., Aarntzen E.H., De Vries I.J., Schuurhuis D.H., Figdor C.G., Adema G.J., Punt C.J. Dendritic cell vaccines in melanoma: from promise to proof?. Crit. Rev. Oncol. Hematol. 2008, 66:118-134.
28. Verdijk P., Aarntzen E.H., Lesterhuis W.J., Boullart A.C., Kok E., van Rossum M.M., Strijk S., Eijckeler F., Bonenkamp J.J., Jacobs J.F., Blokx W., Vankrieken J.H., Joosten I., Boerman O.C., Oyen W.J., Adema G., Punt C.J., Figdor C.G., de Vries I.J. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 2009, 15:2531-2540.
29. Prince H.M., Wall D.M., Ritchie D., Honemann D., Harrrison S., Quach H., Thompson M., Hicks R., Lau E., Davison J., Loudovaris M., Moloney J., Loveland B., Bartholeyns J., Katsifis A., Mileshkin L. In vivo tracking of dendritic cells in patients with multiple myeloma. J. Immunother. 2008, 31:166-179.
30. Read E.J., Keenan A.M., Carter C.S., Yolles P.S., Davey R.J. In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis. J. Nucl. Med. 1990, 31:999-1006.
31. Stevenson H.C., Keenan A.M., Woodhouse C., Ottow R.T., Miller P., Steller E.P., Foon K.A., Abrams P.G., Beman J., Larson S.M., et al. Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis. Cancer Res. 1987, 47:6100-6103.
32. Bernhard H., Neudorfer J., Gebhard K., Conrad H., Hermann C., Nahrig J., Fend F., Weber W., Busch D.H., Peschel C. Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer. Cancer Immunol. Immunother. 2008, 57:271-280.
33. Brand J.M., Meller B., Von Hof K., Luhm J., Bahre M., Kirchner H., Frohn C. Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev. 2004, 13:307-314.
34. Fisher B., Packard B.S., Read E.J., Carrasquillo J.A., Carter C.S., Topalian S.L., Yang J.C., Yolles P., Larson S.M., Rosenberg S.A. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 1989, 7:250-261.
35. Faradji A., Bohbot A., Schmitt-Goguel M., Roeslin N., Dumont S., Wiesel M.L., Lallot C., Eber M., Bartholeyns J., Poindron P., et al. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol. Immunother. 1991, 33:319-326.
36. Griffith K.D., Read E.J., Carrasquillo J.A., Carter C.S., Yang J.C., Fisher B., Aebersold P., Packard B.S., Yu M.Y., Rosenberg S.A. In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J. Natl Cancer Inst. 1989, 81:1709-1717.
37. Pockaj B.A., Sherry R.M., Wei J.P., Yannelli J.R., Carter C.S., Leitman S.F., Carasquillo J.A., Steinberg S.M., Rosenberg S.A., Yang J.C. Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response. Cancer 1994, 73:1731-1737.
38. Meidenbauer N., Marienhagen J., Laumer M., Vogl S., Heymann J., Andreesen R., Mackensen A. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J. Immunol. 2003, 170:2161-2169.
39. Srinivas M., Turner M.S., Janjic J.M., Morel P.A., Laidlaw D.H., Ahrens E.T. In vivo cytometry of antigen-specific T cells using 19F MRI. Magn. Reson. Med. 2009, 62:747-753.
40. Yaghoubi S.S., Jensen M.C., Satyamurthy N., Budhiraja S., Paik D., Czernin J., Gambhir S.S. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat. Clin. Pract. Oncol. 2009, 6:53-58.
41. Kraitchman D.L., Tatsumi M., Gilson W.D., Ishimori T., Kedziorek D., Walczak P., Segars W.P., Chen H.H., Fritzges D., Izbudak I., Young R.G., Marcelino M., Pittenger M.F., Solaiyappan M., Boston R.C., Tsui B.M., Wahl R.L., Bulte J.W. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005, 112:1451-1461.
42. van den Bos E.J., Baks T., Moelker A.D., Kerver W., van Geuns R.J., van der Giessen W.J., Duncker D.J., Wielopolski P.A. Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?. Eur. Heart J. 2006, 27:1620-1626.
43. Ahrens E.T., Srinivas M., Capuano S., Simhan H.N., Schatten G.P. Magnetic resonance imaging of embryonic and fetal development in model systems. Meth. Mol. Med. 2006, 124:87-101.
44. Jirak D., Kriz J., Strzelecki M., Yang J., Hasilo C., White D.J., Foster P.J. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. Magma 2009, 22:257-265.
45. Kriz J., Jirak D., White D., Foster P. Magnetic resonance imaging of pancreatic islets transplanted into the right liver lobes of diabetic mice. Transplant. Proc. 2008, 40:444-448.
46. Boddington S.E., Henning T.D., Jha P., Schlieve C.R., Mandrussow L., DeNardo D., Bernstein H.S., Ritner C., Golovko D., Lu Y., Zhao S., Daldrup-Link H.E. Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase. Cell Transplant. 2010, 19:55-65.
47. Josephs D., Spicer J., O'Doherty M. Molecular imaging in clinical trials. Target Oncol. 2009, 4:151-168.
48. Srinivas M., Morel P.A., Ernst L.A., Laidlaw D.H., Ahrens E.T. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 2007, 58:725-734.
49. Aime S., Barge A., Delli Castelli D., Fedeli F., Mortillaro A., Nielsen F.U., Terreno E. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn. Reson. Med. 2002, 47:639-648.
50. Aime S., Delli Castelli D., Fedeli F., Terreno E. A paramagnetic MRI-CEST agent responsive to lactate concentration. J. Am. Chem. Soc. 2002, 124:9364-9365.
51. Gilad A.A., McMahon M.T., Walczak P., Winnard P.T., Raman V., van Laarhoven H.W., Skoglund C.M., Bulte J.W., van Zijl P.C. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 2007, 25:217-219.
52. Viale A., Aime S. Current concepts on hyperpolarized molecules in MRI. Curr Opin Chem Biol 2010, 14:90-96.
53. Viale A., Reineri F., Santelia D., Cerutti E., Ellena S., Gobetto R., Aime S. Hyperpolarized agents for advanced MRI investigations. Q. J. Nucl. Med. Mol. Imaging 2009, 53:604-617.
54. Riegler J., Wells J.A., Kyrtatos P.G., Price A.N., Pankhurst Q.A., Lythgoe M.F. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 2010.
55. H. Zaidi, M.L. Montandon, A. Alavi, The clinical role of fusion imaging using PET, CT, and MR imaging, Magn Reson Imaging Clin N Am, 18 133-149.
56. Luster M., Karges W., Zeich K., Pauls S., Verburg F.A., Dralle H., Glatting G., Buck A.K., Solbach C., Neumaier B., Reske S.N., Mottaghy F.M. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 2010, 20:527-533.
57. Bybel B., Brunken R.C., DiFilippo F.P., Neumann D.R., Wu G., Cerqueira M.D. SPECT/CT imaging: clinical utility of an emerging technology. Radiographics 2008, 28:1097-1113.
58. Boss A., Kolb A., Hofmann M., Bisdas S., Nagele T., Ernemann U., Stegger L., Rossi C., Schlemmer H.P., Pfannenberg C., Reimold M., Claussen C.D., Pichler B.J., Klose U. Diffusion tensor imaging in a human PET/MR hybrid system. Invest Radiol 2010, 45:270-274.
59. H. Herzog, U. Pietrzyk, N.J. Shah, K. Ziemons, The current state, challenges and perspectives of MR-PET, Neuroimage, 49 2072-2082.
60. Hwang Test W. Development of a quadruple imaging modality by using nanoparticles. Chemistry 2009, 15:9387-9393.
61. Pawelczyk E., Jordan E.K., Balakumaran A., Chaudhry A., Gormley N., Smith M., Lewis B.K., Childs R., Robey P.G., Frank J.A. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS ONE 2009, 4:e6712.
62. Winter E.M., Hogers B., van der Graaf L.M., Gittenberger-de Groot A.C., Poelmann R.E., van der Weerd L. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn Reson Med 2010, 63:817-821.
63. Kraitchman D.L., Bulte J.W. Imaging of stem cells using MRI. Basic Res. Cardiol. 2008, 103:105-113.
64. Rogers W.J., Meyer C.H., Kramer C.M. Technology insight: in vivo cell tracking by use of MRI. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:554-562.
65. L.J. Cruz, P.J. Tacken, R. Fokkink, B. Joosten, M.C. Stuart, F. Albericio, R. Torensma, C.G. Figdor, Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro, J Control Release.
66. Smirnov P., Poirier-Quinot M., Wilhelm C., Lavergne E., Ginefri J.C., Combadiere B., Clement O., Darrasse L., Gazeau F. In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 Tesla MRI system. Magn. Reson. Med. 2008, 60:1292-1297.
67. M. Goetz, T.D. Wang, Molecular imaging in gastrointestinal endoscopy, Gastroenterology, 138 828-833 e821.
68. Singhal S., Nie S., Wang M.D. Nanotechnology applications in surgical oncology. Annu Rev Med 2010, 61:359-373.
69. Leong-Poi H. Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy. Cardiovasc. Res. 2009, 84:190-200.
70. Zhang Y., Ruel M., Beanlands R.S., deKemp R.A., Suuronen E.J., DaSilva J.N. Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr. Pharm. Des. 2008, 14:3835-3853.
71. Lindner J.R. Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc. Res. 2009, 84:182-189.
72. Himmelreich U., Dresselaers T. Cell labeling and tracking for experimental models using magnetic resonance imaging. Methods 2009, 48:112-124.
73. M. Srinivas, A. Heerschap, E.T. Ahrens, C.G. Figdor, I.J. Vries, (19)F MRI for quantitative in vivo cell tracking, Trends Biotechnol., 2010.
74. Sutton E.J., Henning T.D., Pichler B.J., Bremer C., Daldrup-Link H.E. Cell tracking with optical imaging. Eur. Radiol. 2008, 18:2021-2032.
75. Ng L.G., Mrass P., Kinjyo I., Reiner S.L., Weninger W. Two-photon imaging of effector T-cell behavior: lessons from a tumor model. Immunol. Rev. 2008, 221:147-162.
76. Morse M.A., Coleman R.E., Akabani G., Niehaus N., Coleman D., Lyerly H.K. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 1999, 59:56-58.
77. Barnett B.P., Arepally A., Karmarkar P.V., Qian D., Gilson W.D., Walczak P., Howland V., Lawler L., Lauzon C., Stuber M., Kraitchman D.L., Bulte J.W. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 2007, 13:986-991.
78. Karmarkar P.V., Kraitchman D.L., Izbudak I., Hofmann L.V., Amado L.C., Fritzges D., Young R., Pittenger M., Bulte J.W., Atalar E. MR-trackable intramyocardial injection catheter. Magn. Reson. Med. 2004, 51:1163-1172.
79. Lee J.R., Shin J.H., Park J.H., Song S.U., Choi G.S. Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma. Clin. Exp. Dermatol. 2007, 32:541-549.
80. Balakrishnan B., Jayakrishnan A. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials 2005, 26:3941-3951.
81. Bensaid W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24:2497-2502.
82. Furth M.E., Atala A., Van Dyke M.E. Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials 2007, 28:5068-5073.
83. Hannouche D., Terai H., Fuchs J.R., Terada S., Zand S., Nasseri B.A., Petite H., Sedel L., Vacanti J.P. Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells. Tissue Eng. 2007, 13:87-99.
84. Park J.S., Woo D.G., Sun B.K., Chung H.M., Im S.J., Choi Y.M., Park K., Huh K.M., Park K.H. In vitro and in vivo test of PEG/PCL-based hydrogel scaffold for cell delivery application. J. Control. Release 2007, 124:51-59.
85. Serban M.A., Prestwich G.D. Modular extracellular matrices: solutions for the puzzle. Methods 2008, 45:93-98.
86. Pham W., Kobukai S., Hotta C., Gore J.C. Dendritic cells: therapy and imaging. Expert Opin. Biol. Ther. 2009, 9:539-564.
87. Ridolfi R., Riccobon A., Galassi R., Giorgetti G., Petrini M., Fiammenghi L., Stefanelli M., Ridolfi L., Moretti A., Migliori G., Fiorentini G. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J. Transl. Med. 2004, 2:27.
88. Nair S., McLaughlin C., Weizer A., Su Z., Boczkowski D., Dannull J., Vieweg J., Gilboa E. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 2003, 171:6275-6282.
89. Thomas R., Chambers M., Boytar R., Barker K., Cavanagh L.L., MacFadyen S., Smithers M., Jenkins M., Andersen J. Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Res. 1999, 9:474-481.
90. Quillien V., Moisan A., Carsin A., Lesimple T., Lefeuvre C., Adamski H., Bertho N., Devillers A., Leberre C., Toujas L. Biodistribution of radiolabelled human dendritic cells injected by various routes. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:731-741.
91. Schuurhuis D.H., Verdijk P., Schreibelt G., Aarntzen E.H., Scharenborg N., de Boer A., van de Rakt M.W., Kerkhoff M., Gerritsen M.J., Eijckeler F., Bonenkamp J.J., Blokx W., van Krieken J.H., Boerman O.C., Oyen W.J., Punt C.J., Figdor C.G., Adema G.J., de Vries I.J. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients. Cancer Res. 2009, 69:2927-2934.
92. Mackensen A., Krause T., Blum U., Uhrmeister P., Mertelsmann R., Lindemann A. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol. Immunother. 1999, 48:118-122.
93. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
94. Kang W.J., Kang H.J., Kim H.S., Chung J.K., Lee M.C., Lee D.S. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J. Nucl. Med. 2006, 47:1295-1301.
95. L.M. Barbosa da Fonseca, S.S. Xavier, P.H. Rosado de Castro, R.S. Lima, B. Gutfilen, R.C. Goldenberg, A. Maiolino, C.L. Chagas, R.C. Pedrosa, A.C. Campos de Carvalho, Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection, Int J Cardiol.
96. Dedobbeleer C., Blocklet D., Toungouz M., Lambermont M., Unger P., Degaute J.P., Goldman S., Berkenboom G. Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction. J. Cardiovasc. Pharmacol. 2009, 53:480-485.
97. Silva S.A., Sousa A.L., Haddad A.F., Azevedo J.C., Soares V.E., Peixoto C.M., Soares A.J., Issa A.F., Felipe L.R., Branco R.V., Addad J.A., Moreira R.C., Tuche F.A., Mesquita C.T., Drumond C.C., Junior A.O., Rochitte C.E., Luz J.H., Rabischoffisky A., Nogueira F.B., Vieira R.B., Junior H.S., Borojevic R., Dohmann H.F. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transplant. 2009, 18:343-352.
98. Schachinger V., Aicher A., Dobert N., Rover R., Diener J., Fichtlscherer S., Assmus B., Seeger F.H., Menzel C., Brenner W., Dimmeler S., Zeiher A.M. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 2008, 118:1425-1432.
99. Caveliers V., De Keulenaer G., Everaert H., Van Riet I., Van Camp G., Verheye S., Roland J., Schoors D., Franken P.R., Schots R. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease. Q. J. Nucl. Med. Mol. Imaging 2007, 51:61-66.
100. Goussetis E., Manginas A., Koutelou M., Peristeri I., Theodosaki M., Kollaros N., Leontiadis E., Theodorakos A., Paterakis G., Karatasakis G., Cokkinos D.V., Graphakos S. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells 2006, 24:2279-2283.
101. Blocklet D., Toungouz M., Berkenboom G., Lambermont M., Unger P., Preumont N., Stoupel E., Egrise D., Degaute J.P., Goldman M., Goldman S. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006, 24:333-336.